Genetics of Alzheimer's disease: a centennial review
- PMID: 17659183
- PMCID: PMC2735049
- DOI: 10.1016/j.ncl.2007.03.009
Genetics of Alzheimer's disease: a centennial review
Abstract
Alzheimer's disease (AD) genetics may be one of the most prolifically published areas in medicine and biology. Three early-onset AD genes with causative mutations (APP, PSEN1, PSEN2) and one late-onset AD susceptibility gene, apolipoprotein E (APOE), exist with ample biologic, genetic, and epidemiologic data. Evidence suggests a significant genetic component underlying AD that is not explained by the known genetic risk factors. This article summarizes the evidence for the genetic component in AD and the identification of the early-onset familial AD genes and APOE, and examines the current state of knowledge about additional AD susceptibility loci and alleles. The future directions for genetic research in AD as a common and complex condition are also discussed.
Figures




Similar articles
-
The current status of Alzheimer's disease genetics: what do we tell the patients?Pharmacol Res. 2004 Oct;50(4):385-96. doi: 10.1016/j.phrs.2003.11.018. Pharmacol Res. 2004. PMID: 15304236 Review.
-
Of replications and refutations: the status of Alzheimer's disease genetic research.Curr Neurol Neurosci Rep. 2001 Sep;1(5):442-50. doi: 10.1007/s11910-001-0104-9. Curr Neurol Neurosci Rep. 2001. PMID: 11898555 Review.
-
Molecular Genetics of Early- and Late-Onset Alzheimer's Disease.Curr Gene Ther. 2021;21(1):43-52. doi: 10.2174/1566523220666201123112822. Curr Gene Ther. 2021. PMID: 33231156 Review.
-
A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease.J Clin Psychiatry. 2007 Apr;68(4):613-8. doi: 10.4088/jcp.v68n0419. J Clin Psychiatry. 2007. PMID: 17474819
-
A genetic screen of the mutations in the Korean patients with early-onset Alzheimer's disease.Clin Interv Aging. 2016 Dec 15;11:1817-1822. doi: 10.2147/CIA.S116724. eCollection 2016. Clin Interv Aging. 2016. PMID: 28008242 Free PMC article.
Cited by
-
Molecular Mechanisms and Genetics of Oxidative Stress in Alzheimer's Disease.J Alzheimers Dis. 2019;72(4):981-1017. doi: 10.3233/JAD-190863. J Alzheimers Dis. 2019. PMID: 31744008 Free PMC article. Review.
-
Personality as a moderator of cognitive stimulation in older adults at high risk for cognitive decline.Res Gerontol Nurs. 2014 Jul-Aug;7(4):159-70. doi: 10.3928/19404921-20140311-01. Epub 2014 Mar 18. Res Gerontol Nurs. 2014. PMID: 24635006 Free PMC article. Clinical Trial.
-
Validating GWAS-Identified Risk Loci for Alzheimer's Disease in Han Chinese Populations.Mol Neurobiol. 2016 Jan;53(1):379-390. doi: 10.1007/s12035-014-9015-z. Epub 2014 Dec 3. Mol Neurobiol. 2016. PMID: 25452228
-
Mutations in presenilin 2 and its implications in Alzheimer's disease and other dementia-associated disorders.Clin Interv Aging. 2015 Jul 14;10:1163-72. doi: 10.2147/CIA.S85808. eCollection 2015. Clin Interv Aging. 2015. PMID: 26203236 Free PMC article.
-
Toward precision medicine in Alzheimer's disease.Ann Transl Med. 2016 Mar;4(6):107. doi: 10.21037/atm.2016.03.05. Ann Transl Med. 2016. PMID: 27127760 Free PMC article. Review.
References
-
- Mayeux R. Epidemiology of neurodegeneration. Annu Rev Neurosci. 2003;26:81–104. - PubMed
-
- Rice DP, Fillit HM, Max W, Knopman DS, Lloyd JR, Duttagupta S. Prevalence, costs, and treatment of Alzheimer’s disease and related dementia: a managed care perspective. Am J Manag Care. 2001 Aug;7(8):809–818. - PubMed
-
- Borenstein AR, Copenhaver CI, Mortimer JA. Early-life risk factors for Alzheimer disease. Alzheimer Dis Assoc Disord. 2006 Jan–Mar;20(1):63–72. - PubMed
-
- Whalley LJ, Dick FD, McNeill G. A life-course approach to the aetiology of late-onset dementias. Lancet Neurol. 2006 Jan;5(1):87–96. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous